Issue 17, 2014

Approaching the in vitro clinical trial: engineering organs on chips

Abstract

In vitro cell culture and animal models are the most heavily relied upon tools of the pharmaceutical industry. When these tools fail, the results are costly and have at times, proven deadly. One promising new tool to enhance preclinical development of drugs is Organs on Chips (OOCs), proposed as a clinically and physiologically relevant means of modeling health and disease. Bringing the patient from bedside to bench in this form requires that the design, build, and test of OOCs be founded in clinical observations and methods. By creating OOCs as models of the patient, the industry may be better positioned to evaluate medicinal therapeutics

Graphical abstract: Approaching the in vitro clinical trial: engineering organs on chips

Article information

Article type
Frontier
Submitted
04 Mar 2014
Accepted
28 Apr 2014
First published
15 May 2014

Lab Chip, 2014,14, 3181-3186

Approaching the in vitro clinical trial: engineering organs on chips

A. K. Capulli, K. Tian, N. Mehandru, A. Bukhta, S. F. Choudhury, M. Suchyta and K. K. Parker, Lab Chip, 2014, 14, 3181 DOI: 10.1039/C4LC00276H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements